The proposed study builds upon the existing recruitment of study subjects and procurement of epidemiologic data and blood samples from two ongoing studies of lung cancer, led by Drs. Margaret Spitz and Waun Ki Hong. The application proposes to validate the findings of a preliminary case-control study which revealed that the level of in vitro benzo[a]pyrene diol epoxide (BPDE)-induced DNA adducts was significantly associated with the risk of lung cancer. The rationale for developing this biomarker is not given the same in-vitro exposure to smoking-related carcinogens, cells from some individuals did not remove carcinogen-induced adducts sufficiently, indicating an increased risk of developing smoking-related cancer. The study will evaluate the usefulness of this new in vitro-induced DNA adduct assay and identify individuals who may be susceptible to smoking-related cancers. Using the study protocol, personnel, and data-collection instruments currently in operation, the preliminary study of 21 cases and 41 controls to a case-control will be expanded to a study of 250 lung-cancer cases and 250 healthy controls (matched by age, sex ethnicity and smoking status). The application outlines the following Specific Aims: 1) to determine the association between the levels of in vitro-induced carcinogen adducts and risk of lung cancer; 2) to determine the correlation between levels of BPE-induced adducts and DNA repair capacity; and 3) to determine the association of the levels of BPE-induced DNA adducts with other related susceptibility factors and biomarkers for lung-cancer risk. The level of DNA adducts induced by in vitro by an ultimate carcinogen (BPDE) largely reflects the level of overall genomic repair capacity of the whole cells plus cellular detoxification. It is hypothesized that the in vitro-induced adducts associated with lung cancer susceptibility will substantiate the predictive role of this new BPDE-induced DNA adduct assay in identifying subgroups of smokers at particularly high risk for developing lung cancer and further elucidate the mechanisms of tobacco carcinogenesis. Such high-risk individuals would be targetted for intensive smoking cessation interventions, could be enrolled in chemoprevention trials and might be suitable for screening programs, not appropriate for the general population.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074851-03
Application #
2896037
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Patel, Appasaheb1 R
Project Start
1997-07-15
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2001-06-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Organized Research Units
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Guan, Xiaoxiang; Wang, Li-E; Liu, Zhensheng et al. (2013) Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med 17:873-8
Wang, Li-E; Gorlova, Olga Y; Ying, Jun et al. (2013) Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res 73:256-64
Yin, Ming; Liao, Zhongxing; Yuan, Xianglin et al. (2012) Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Cancer Sci 103:945-50
Wang, Luo; Lu, Jiachun; An, Jiaze et al. (2007) Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer 57:143-51
Shen, Hongbing; Wei, Qingyi; Pillow, Patricia C et al. (2003) Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev 12:980-6
Wang, Li-E; Cheng, Lie; Spitz, Margaret R et al. (2003) Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 42:1-8
Qiao, Yawei; Spitz, Margaret R; Shen, Hongbing et al. (2002) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 23:295-9
Shen, Hongbing; Wang, Luo; Spitz, Margaret R et al. (2002) A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 62:4992-5
Shen, Hongbing; Spitz, Margaret R; Qiao, Yawei et al. (2002) Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer 36:243-7
Shen, Hongbing; Sturgis, Erich M; Dahlstrom, Kristina R et al. (2002) A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 99:869-72

Showing the most recent 10 out of 30 publications